Cargando…
Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19
The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910139/ https://www.ncbi.nlm.nih.gov/pubmed/33680348 http://dx.doi.org/10.1016/j.csbj.2021.02.009 |
_version_ | 1783656068635688960 |
---|---|
author | Chavarría, Adrián Palacios Vázquez, Rafael Ricardo Valdez Cherit, José Guillermo Domínguez Bello, Héctor Herrera Suastegui, Humberto Castillejos Moreno-Castañeda, Lidia Alanís Estrada, Gabriela Hernández, Fabián González-Marcos, Omar Saucedo-Orozco, Huitzilihuitl Manzano-Pech, Linaloe Márquez-Velasco, Ricardo Guarner-Lans, Verónica Pérez-Torres, Israel Soto, Maria Elena |
author_facet | Chavarría, Adrián Palacios Vázquez, Rafael Ricardo Valdez Cherit, José Guillermo Domínguez Bello, Héctor Herrera Suastegui, Humberto Castillejos Moreno-Castañeda, Lidia Alanís Estrada, Gabriela Hernández, Fabián González-Marcos, Omar Saucedo-Orozco, Huitzilihuitl Manzano-Pech, Linaloe Márquez-Velasco, Ricardo Guarner-Lans, Verónica Pérez-Torres, Israel Soto, Maria Elena |
author_sort | Chavarría, Adrián Palacios |
collection | PubMed |
description | The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-acetylcysteine (NAC) and Melatonin (MT) increase the intracellular content of GSH, kidnap free radicals and protect DNA, proteins in the cytosol and lipids in cell membranes. Pentoxifylline (Px) has anti-inflammatory activities. Here we evaluate the effect of Vit C, Vit E, NAC, and MT plus Px in COVID-19 patients with moderate and severe pneumonia. 110 patients of either sex were included. They were divided into five groups with 22 patients each. Group 1 received Vit C + Px, group 2 Vit E + Px, group 3 NAC + Px, group 4 MT + Px, and group 5 only Px. Oxidative stress (OS) markers such as lipid peroxidation (LPO) levels, total antioxidant capacity (TAC) and nitrites (NO(2)(–)) were evaluated in plasma. The antioxidant therapy improved the survival scores including the Sequential Organ Failure Assessment (SOFA), the Acute Physiology and chronic Health Evaluation II (Apache II), the Simplified Acute Physiology Score II (SAPS II), the Critical Illness Risk Score, Launched during COVID-19 crisis (COVIDGRAM) and the Glasgow Coma Scale (GCS). We found that LPO (p≤0.04) and inflammation markers such as interleukin-6 (IL-6, p≤ 0.01), C reactive protein (CRP, p ≤ 0.01) and procalcitonin (PCT, p ≤ 0.05) were elevated. TAC (p ≤ 0.03) and NO(2)(–) (p ≤ 0.04) found themselves diminished in diminished in COVID-19 patients upon admission to the hospital. The different antioxidants reversed this alteration at the end of the treatment. The treatment with antioxidant supplements such as Vit C, E, NAC, and MT plus Px could decelerate the aggressive and lethal development of COVID-19. Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO(2)(–). |
format | Online Article Text |
id | pubmed-7910139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-79101392021-03-01 Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 Chavarría, Adrián Palacios Vázquez, Rafael Ricardo Valdez Cherit, José Guillermo Domínguez Bello, Héctor Herrera Suastegui, Humberto Castillejos Moreno-Castañeda, Lidia Alanís Estrada, Gabriela Hernández, Fabián González-Marcos, Omar Saucedo-Orozco, Huitzilihuitl Manzano-Pech, Linaloe Márquez-Velasco, Ricardo Guarner-Lans, Verónica Pérez-Torres, Israel Soto, Maria Elena Comput Struct Biotechnol J Research Article The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-acetylcysteine (NAC) and Melatonin (MT) increase the intracellular content of GSH, kidnap free radicals and protect DNA, proteins in the cytosol and lipids in cell membranes. Pentoxifylline (Px) has anti-inflammatory activities. Here we evaluate the effect of Vit C, Vit E, NAC, and MT plus Px in COVID-19 patients with moderate and severe pneumonia. 110 patients of either sex were included. They were divided into five groups with 22 patients each. Group 1 received Vit C + Px, group 2 Vit E + Px, group 3 NAC + Px, group 4 MT + Px, and group 5 only Px. Oxidative stress (OS) markers such as lipid peroxidation (LPO) levels, total antioxidant capacity (TAC) and nitrites (NO(2)(–)) were evaluated in plasma. The antioxidant therapy improved the survival scores including the Sequential Organ Failure Assessment (SOFA), the Acute Physiology and chronic Health Evaluation II (Apache II), the Simplified Acute Physiology Score II (SAPS II), the Critical Illness Risk Score, Launched during COVID-19 crisis (COVIDGRAM) and the Glasgow Coma Scale (GCS). We found that LPO (p≤0.04) and inflammation markers such as interleukin-6 (IL-6, p≤ 0.01), C reactive protein (CRP, p ≤ 0.01) and procalcitonin (PCT, p ≤ 0.05) were elevated. TAC (p ≤ 0.03) and NO(2)(–) (p ≤ 0.04) found themselves diminished in diminished in COVID-19 patients upon admission to the hospital. The different antioxidants reversed this alteration at the end of the treatment. The treatment with antioxidant supplements such as Vit C, E, NAC, and MT plus Px could decelerate the aggressive and lethal development of COVID-19. Antioxidant therapy can be effective in this pandemia since it improves the survival scores including SOFA, Apache II, SAPS II, COVIDGRAM, GCS by lowering the LPO, IL-6, CRP, PCT and increasing systemic TAC and NO(2)(–). Research Network of Computational and Structural Biotechnology 2021-02-27 /pmc/articles/PMC7910139/ /pubmed/33680348 http://dx.doi.org/10.1016/j.csbj.2021.02.009 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Chavarría, Adrián Palacios Vázquez, Rafael Ricardo Valdez Cherit, José Guillermo Domínguez Bello, Héctor Herrera Suastegui, Humberto Castillejos Moreno-Castañeda, Lidia Alanís Estrada, Gabriela Hernández, Fabián González-Marcos, Omar Saucedo-Orozco, Huitzilihuitl Manzano-Pech, Linaloe Márquez-Velasco, Ricardo Guarner-Lans, Verónica Pérez-Torres, Israel Soto, Maria Elena Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title | Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title_full | Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title_fullStr | Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title_full_unstemmed | Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title_short | Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 |
title_sort | antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by covid-19 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910139/ https://www.ncbi.nlm.nih.gov/pubmed/33680348 http://dx.doi.org/10.1016/j.csbj.2021.02.009 |
work_keys_str_mv | AT chavarriaadrianpalacios antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT vazquezrafaelricardovaldez antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT cheritjoseguillermodominguez antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT bellohectorherrera antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT suasteguihumbertocastillejos antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT morenocastanedalidia antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT alanisestradagabriela antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT hernandezfabian antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT gonzalezmarcosomar antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT saucedoorozcohuitzilihuitl antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT manzanopechlinaloe antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT marquezvelascoricardo antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT guarnerlansveronica antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT pereztorresisrael antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 AT sotomariaelena antioxidantsandpentoxifyllineascoadjuvantmeasurestostandardtherapytoimproveprognosisofpatientswithpneumoniabycovid19 |